Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A y/Ta mice

Autor: Tanimoto, Mitsuo, Gohda, Tomohito, Kaneko, Shigeru, Hagiwara, Shinji, Murakoshi, Maki, Aoki, Tatsuya, Yamada, Kaori, Ito, Takamichi, Matsumoto, Masakazu, Horikoshi, Satoshi, Tomino, Yasuhiko
Zdroj: In Metabolism 2007 56(2):160-167
Databáze: ScienceDirect